We are live on ! Find out more
PMN icon

ProMIS Neurosciences
PMN

17 hedge funds and large institutions have $12.6M invested in ProMIS Neurosciences in 2024 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,577% more capital inflows, than outflows

Capital inflows: $10.6M | Capital outflows: $396K

400% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 1

150% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 2

21% more funds holding

Funds holding: 14 → 17 (+3)

16.54% more ownership

Funds ownership: 17.21% → 33.75% (+17%)

Holders
17
Holders Change
+3
Holders Change %
+21.43%
% of All Funds
0.24%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
5
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Great Point Partners
Great Point Partners
Connecticut
+$4.17M
2
Armistice Capital
Armistice Capital
New York
+$3.99M
3
ACM
Altium Capital Management
New York
+$868K
4
Ally Bridge Group
Ally Bridge Group
New York
+$796K
5
Sphera Funds Management
Sphera Funds Management
Israel
+$172K

Top Sellers

Rank Fund Capital Flow
1
Affinity Asset Advisors
Affinity Asset Advisors
New York
-$351K
2
Hara Capital
Hara Capital
Washington
-$44.1K
3
Wells Fargo
Wells Fargo
California
-$30
4
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management
Wisconsin
-$6

PMN Hedge Fund Activity: Q3 2024 in Review

17 of the 6,989 institutional investors tracked by Wall St. Rank reported a position in ProMIS Neurosciences (PMN) for Q3 2024, worth a combined $12.6M — up 157% from $4.9M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new PMN positions and 2 closed out — a net gain of 3 holders — while 5 added to existing stakes and 1 trimmed.

The largest buyer was Great Point Partners, opening a new position worth an estimated $4.17M. The largest seller was Affinity Asset Advisors, cutting an estimated $351K.

  • 17 institutional investors held ProMIS Neurosciences (PMN) as of Q3 2024, up from 14 in Q2 2024.
  • Funds reported $12.6M of ProMIS Neurosciences stock for Q3 2024, up 157% quarter-over-quarter.
  • 5 funds opened new ProMIS Neurosciences positions in Q3 2024 and 2 closed out, a net change of +3 holders.
  • The largest ProMIS Neurosciences buyer in Q3 2024 was Great Point Partners, an estimated $4.17M added.
  • The largest ProMIS Neurosciences seller in Q3 2024 was Affinity Asset Advisors, an estimated $351K sold.

Based on aggregated 13F filings for Q3 2024.